Featured Research

from universities, journals, and other organizations

Collagen Level Can Impact Risk Of Incontinence And Prolapse In Women

Date:
March 22, 2004
Source:
Temple University
Summary:
Decreased collagen levels might make some women more susceptible to pelvic organ prolapse and urinary incontinence, according to a new study by physicians at Temple University School of Medicine and Temple University Hospital.

Decreased collagen levels might make some women more susceptible to pelvic organ prolapse and urinary incontinence, according to a new study by physicians at Temple University School of Medicine and Temple University Hospital. The study, "Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence," appears in a recent issue of the American Journal of Obstetrics and Gynecology.

According to study author Oz Harmanli, M.D., assistant professor of obstetrics and gynecology, "We often blame prolapse or incontinence on childbirth, aging or chronic straining. But such is not the experience for all women. Some older women enjoy strong pelvic support in their 80s, while some women in their 30s suffer from weak pelvic floors, regardless of other factors.

"Our study examined whether the connective tissue, specifically collagen, influenced risk of pelvic floor disorders," said Harmanli. Collagen is the substance that holds all of our bodily tissues together. Other studies have looked at collagen levels in already-prolapsed tissue. The Temple study looked at tissue from the cervix, the cone-shaped opening to the uterus, which is not a support structure and therefore not affected by prolapse.

"We found that women with prolapse and incontinence had decreased amounts of collagen in the cervix, regardless of all other factors. This supports the theory that there's an intrinsic factor that can contribute to these problems, and everything else, such as childbirth and obesity, is additive," said Harmanli.

The next step is a larger-scale study to determine whether these findings hold true in a larger group of women. "What we learn could improve our ability to predict which women are at higher risk for these problems and help them take preventive measures," said Harmanli.


Story Source:

The above story is based on materials provided by Temple University. Note: Materials may be edited for content and length.


Cite This Page:

Temple University. "Collagen Level Can Impact Risk Of Incontinence And Prolapse In Women." ScienceDaily. ScienceDaily, 22 March 2004. <www.sciencedaily.com/releases/2004/03/040322080415.htm>.
Temple University. (2004, March 22). Collagen Level Can Impact Risk Of Incontinence And Prolapse In Women. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/03/040322080415.htm
Temple University. "Collagen Level Can Impact Risk Of Incontinence And Prolapse In Women." ScienceDaily. www.sciencedaily.com/releases/2004/03/040322080415.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins